NorthStar Medical Radioisotopes - About the company
NorthStar Medical Radioisotopes is a series B company based in Madison (United States), founded in 2006 by George Messina. It operates as a Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market. NorthStar Medical Radioisotopes has raised $15.1M in funding from Hendricks Holding and Stateline Angels. The company has 24 active competitors, including 6 funded and 4 that have exited. Its top competitors include companies like ARTMS, Curium and Alsachim.
Company Details
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market. Its patented technologies include innovative non-uranium-based molybdenum-99 production methods, a novel separation chemistry system, and tools for the nuclear medicine market. Products include Non-HEU 99-Molybdenum and RadioGenix intelligent isotope separation system. Claims to be the first domestic producer of 99-Molybdenum and the only supplier of Non-HEU material.
Key Metrics
Founded Year
2006
Location
Madison, United States
Stage
Series B
Total Funding
$15.1M in 16 rounds
Latest Funding Round
Investors
Ranked
1st among 24 active competitors
Employee Count
308 as on Mar 31, 2026
Sign up to download NorthStar Medical Radioisotopes' company profile
NorthStar Medical Radioisotopes's funding and investors
NorthStar Medical Radioisotopes has raised a total funding of $15.1M over 16 rounds. Its first funding round was on Mar 11, 2010. Its latest funding round was a Grant (prize money) round on May 13, 2025 for $*****. 1 investor participated in its latest round. NorthStar Medical Radioisotopes has 6 institutional investors.
Here is the list of recent funding rounds of NorthStar Medical Radioisotopes:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 13, 2025 | 8202421 | Grant (prize money) | 2132076 | 8946903 | 3353028 | 3270182 |
Jul 23, 2019 | 4907822 | Grant (prize money) | 5797095 | 2344668 | 2772462 | |
Apr 23, 2019 | 7485697 | Conventional Debt | 9233107 | 5528329 | 2609167 |
View details of NorthStar Medical Radioisotopes's funding rounds and investors
NorthStar Medical Radioisotopes' founders and board of directors
Founder? Claim ProfileThe founders of NorthStar Medical Radioisotopes is George Messina.
Here are the details of NorthStar Medical Radioisotopes' key team members:
- George Messina: Co-Founder & CEO of NorthStar Medical Radioisotopes.
NorthStar Medical Radioisotopes' employee count trend
NorthStar Medical Radioisotopes has 308 employees as of Mar 26. Here is NorthStar Medical Radioisotopes's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NorthStar Medical Radioisotopes's Competitors and alternates
Top competitors of NorthStar Medical Radioisotopes include ARTMS, Curium and Alsachim. Here is the list of Top 10 competitors of NorthStar Medical Radioisotopes, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | NorthStar Medical Radioisotopes 2006, Madison (United States), Series B | Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market | $15.1M | 57/100 | |
2nd | Provider and developer of radioisotope technologies | $26.6M | 57/100 | ||
3rd | Specialty developer, manufacturer & distributor of radiopharmaceuticals | - | 56/100 | ||
4th | Custom synthesis of stable radioisotopes & analytical services for pharmaceutical and biotech companies | - | 42/100 | ||
5th | ATOMIC ALCHEMY 2017, Idaho Falls (United States), Acquired | Limited information available | $150K | 40/100 | |
6th | AZI 2017, Bunker Hill (United States), Series C | Developer of radiopharmaceuticals for imaging purposes | $58.3M | - | 39/100 |
7th | Cassia 2005, San Diego (United States), Unfunded | Isotope labelling services for biomolecules | - | - | 37/100 |
8th | Ground Fluor Pharmaceuticals 2012, Lincoln (United States), Series A | Biomedical company developing proprietary new chemistry for the synthesis of pharmaceutical compounds | - | 36/100 | |
9th | CellBion 2010, Seoul (South Korea), Public | Radioactive probes for imaging | - | 33/100 | |
10th | Am Chemicals 2003, Oceanside (United States), Unfunded | Oligonucleotide synthesis solutions: solid supports, reagents, and expert services | - | - | 33/100 |
Looking for more details on NorthStar Medical Radioisotopes's competitors? Click here to see the top ones
NorthStar Medical Radioisotopes's Investments and acquisitions
NorthStar Medical Radioisotopes has made no investments or acquisitions yet.
News related to NorthStar Medical Radioisotopes
Media has covered NorthStar Medical Radioisotopes for a total of 10 events in the last 1 year, 4 of them have been about people movement and 2 about company updates.
•
•
Bioemtech, Northstar Medical Radioisotopes Reach Agreement For Ac-225 SupplyContract Pharma•Feb 18, 2026•BioEmission Tech, NorthStar Medical Radioisotopes
•
•
Leadership Changes at NorthStar Medical RadioisotopesContract Pharma•Dec 16, 2025•NorthStar Medical Radioisotopes
•
•
•
•
NorthStar Medical Technologies Appoints Jon Coulter as Non-Executive ChairmanBusiness Wire•Aug 11, 2025•NorthStar Medical Radioisotopes
•
NorthStar & YAP team up to develop and produce radiopharmaceuticals.Business Wire•Jan 08, 2025•NorthStar Medical Radioisotopes, YAPtx
•
Are you a Founder ?
FAQs about NorthStar Medical Radioisotopes
Explore our recently published companies
- Capitalsfb.com - 2018 founded, Unfunded company
- Specule - Delhi based, 2017 founded, Unfunded company
- Tech Hive Technologies - Rawalpindi based, 2017 founded, Unfunded company
- Wise Accelerate - Hanoi based, 2021 founded, Unfunded company
- AblyCon Global - Bengaluru based, 2014 founded, Unfunded company
- Civoya - 2025 founded, Unfunded company